ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2016

Jul 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2016-06-30

Reporting Person: Anzalone Christopher Richard (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-30	Common Stock	M	15772	$5.09	Acquired	1117233	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-30	Common Stock Warrant	$5.09	X	15772	Disposed	2016-06-30	Common Stock (15772)	Direct

Footnotes

F1: This transaction represents an exercise of warrants exempted pursuant to Rule 16b-3.